238Oral (PO) Valganciclovir (VGC) for preemptive therapy of Cytomegalovirus (CMV) Antigenemia (AG) in hematopoietic stem cell transplant (HSCT) recipients
Open Access
- 1 February 2003
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 9 (2) , 132
- https://doi.org/10.1016/s1083-8791(03)80223-9
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: